
Coloplast A/S
Coloplast A/S is a Denmark-based company in the Healthcare sector with a market capitalisation of $16.0B. Its FinScore is 62/100; its highest-scoring layer is Quality (73) and its lowest is Growth (40). The shares trade at 38.5x trailing earnings and are down 12% year to date.
Share price performance
About Coloplast A/S
www.coloplast.comColoplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- HQ
- Denmark
- Fiscal year-end
- September
- Trading currency
- DKK
- Reporting currency
- DKK
- Fundamentals updated
- 5 days ago
- Market cap
- $16.0B
- Shares outstanding
- 225.4M
- P/E (TTM)
- 38.5x
- Dividend yield (TTM)
- 4.87%
- Beta (issuer)
- 0.56
- Revenue (latest FY)
- DKK 27.9B
Revenue breakdown
Revenue split not available
FinScore
As of 2026-10-19Snapshot
Ownership
Holder data is not available for this company yet.
Sign up or log in to see Analysis
Analysis for Coloplast A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Financials
Financials for Coloplast A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Estimates
Estimates for Coloplast A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Peers
Peers for Coloplast A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see Valuation
Valuation for Coloplast A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.
Sign up or log in to see News
News for Coloplast A/S is available to Finryse members. The Overview stays open to everyone; creating an account is free.